1. P725: METABOLIC PROPERTIES OF MESENCHYMAL STROMAL CELLS IN MYELODYSPLASTIC SYNDROMES. (23rd June 2022) Authors: Balaian, E.; Sockel, K.; Cross, M.; Funk, A.; Bornhäuser, M.; Chavakis, T.; Wobus, M. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 620 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P752: TARGETING S100A9 IN THE MYELODYSPLASTIC INFLAMMATORY BONE MARROW MICROENVIRONMENT BY TASQUINIMOD IMPROVES THE SUPPORTIVE FUNCTION OF MESENCHYMAL STROMAL CELLS. (23rd June 2022) Authors: Wobus, M.; Balaian, E.; Lissner, M.; Towers, R.; Oelschlägel, U.; Wehner, R.; Chavakis, T.; Törngren, M.; Eriksson, H.; Bondesson, E.; Platzbecker, U.; Bornhäuser, M.; Sockel, K. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 647 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Topic: AS06-Prognosis/AS06a-Prognostic factors of outcome and risk assessment: PROGNOSTIC SIGNIFICANCE OF HISTOLOGICAL BLAST COUNT IN MYELODYSPLASTIC SYNDROMES. (September 2021) Authors: Bär, T.; Bornhäuser, M.; Kroschinsky, F.; Sockel, K.; Balaian, E.; Corinna, J.; Platzbecker, U.; Michael, K. Journal: Leukemia research Issue: Volume 108(2021)Supplement Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗